Alteplase Injection (Cathflo Activase) Shortage
Last Updated: November 22, 2024
Status: Current
Reason for the Shortage
-
- On May 28, 2024, Genentech issued a voluntary recall of two batches (batches 3618873 and 3618858) of Cathflo Activase due to defective stoppers. Defective stoppers may not seal properly resulting in potential container closure integrity and sterility concerns. Additional information can be found at https://www.gene.com/download/pdf/Cathflo-Activase_DHCP_Important_Drug_Warning_2024-05-28.pdf.
Available Products
-
- Cathflo Activase intravenous lyophilized powder for injection, Genentech, 2 mg, vial, 1 count, NDC 50242-0041-64
- Cathflo Activase intravenous lyophilized powder for injection, Genentech, 2 mg, vial, 10 count, NDC 50242-0041-10
Updated
Updated November 22, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 21, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.